Melanocytic nevus overview

Jump to navigation Jump to search

Melanocytic nevus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Melanocytic Nevus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Melanocytic nevus overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Melanocytic nevus overview

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Melanocytic nevus overview

CDC on Melanocytic nevus overview

Melanocytic nevus overview in the news

Blogs on Melanocytic nevus overview

Directions to Hospitals Treating Melanocytic nevus

Risk calculators and risk factors for Melanocytic nevus overview

Editors-In-Chief: Martin I. Newman, M.D., FACS, Cleveland Clinic Florida, [1]; Michel C. Samson, M.D., FRCSC, FACS [2]

Overview

A mole, technically known as a melanocytic nevus, is a small, dark spot on human skin. According to the American Academy of Dermatology, the majority of moles appear during the first two decades of a person’s life while about one in every 100 babies are born with moles. Acquired moles are a form of benign neoplasm, while congenitalmoles are considered a minor malformation, or hamartoma. A mole can be either subdermal (composed of melanin), or a pigmented growth on the skin, formed mostly of a type of cell known as melanocytes. The high concentration of the body’s pigmenting agent, melanin, is responsible for their dark color. Moles are a member of the family of skin lesions known as naevi.

Historical Perspective

At one time in the 1950s and 60s, (and, to lesser extent, currently) a mole was known as a “beauty mark” when it appeared in certain spots on a woman’s face. Examples include Marilyn Monroe, model Cindy Crawford and singer Madonna. Madonna's facial mole -- below her right nostril -- has been surgically removed.

Pathophysiology

Melanocytic nevus is a benign growth on the skin (usually tan, brown, or flesh-colored) that contains a cluster of melanocytes and surrounding supportive tissue.

Causes

Scientists suspect that overexposure to ultraviolet light, including excessive sunlight, may play a role in the formation of acquired moles.[1] However, more research is needed in this area.

Differentiating melanocytic nevus from other diseases

Melanocytic nevus must be differentiate from dysplastic nevus, melanoma and epidermal nevus.

Epidemiology and Demographics

Darker skin shades tend to have fewer moles compared to fair complexion.

Risk Factors

Most important risk factor for melanocytic nevus is sunlight however, genetic predisposition is an important factor as well.

Prognosis

Vast majority of moles are benign. Nonetheless, the National (U.S.) Cancer Institute reported 59,940 new cases of melanoma by June, 2007, with 8,110 deaths.[2]

History and Symptoms

Physical Examination

Medical Therapy

Surgery

References

  1. Arne van Schanke, Gemma M.C.A.L. van Venrooij, Marjan J. Jongsma, H. Alexander Banus, Leon H.F. Mullenders, Henk J. van Kranen and Frank R. de Gruijl. Induction of Nevi and Skin Tumors in Ink4a/ArfXpa Knockout Mice by Neonatial, Intermittent, or Chronic UVB Exposures. Cancer Res 2006; 66 (5), 2608-15.
  2. http://www.nci.nih.gov/cancertopics/types/melanoma


Template:WikiDoc Sources